Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

CDSCO Panel Rejects Troikaa Pharma's High-Strength Paracetamol Injection Citing Safety Concerns Pharma News

CDSCO Panel Rejects Troikaa Pharma's High-Strength Paracetamol Injection Citing Safety Concerns

  • 25 October 2025
  • 1 week ago

CDSCO Flags 112 Drug Batches Including Telmisartan, Pantoprazole, Cefixime, Glimepiride as Not of Standard Quality Pharma News

CDSCO Flags 112 Drug Batches Including Telmisartan, Pantoprazole, Cefixime, Glimepiride as Not of Standard Quality

  • 25 October 2025
  • 1 week ago

CDSCO Panel Seeks More Toxicity Data from Macleods on Semaglutide Injection Pre-Filled Pens Pharma News

CDSCO Panel Seeks More Toxicity Data from Macleods on Semaglutide Injection Pre-Filled Pens

  • 23 October 2025
  • 1 week ago

Torrent Pharma Receives SEC Approval to Market Alogliptin-Metformin FDC, Asked to Conduct Phase IV Trial Pharma News

Torrent Pharma Receives SEC Approval to Market Alogliptin-Metformin FDC, Asked to Conduct Phase IV Trial

  • 23 October 2025
  • 1 week ago

Beta Drugs' Methotrexate Oral Solution Gets SEC Manufacturing, Marketing Nod Pharma News

Beta Drugs' Methotrexate Oral Solution Gets SEC Manufacturing, Marketing Nod

  • 22 October 2025
  • 1 week ago

Unique Pharma Asked To Revise BE Study Protocol for Cilnidipine-Metoprolol FDC Pharma News

Unique Pharma Asked To Revise BE Study Protocol for Cilnidipine-Metoprolol FDC

  • 22 October 2025
  • 1 week ago

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India Pharma News

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India

  • 21 October 2025
  • 1 week ago

Biocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths Pharma News

Biocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths

  • 21 October 2025
  • 1 week ago

Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection Pharma News

Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection

  • 20 October 2025
  • 1 week ago

CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis Pharma News

CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis

  • 20 October 2025
  • 1 week ago

Recent News

Himachal notifies Resident doctor policy 2025

  • 02 November, 2025

Pfizer files lawsuit against Metsera, its Director...

  • 02 November, 2025

Health Ministry achieves 3 Guinness World Records...

  • 02 November, 2025

Roche gets CE mark for Elecsys Dengue Ag test to d...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.